Farther Finance Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Farther Finance Advisors’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$258K	Buy	3,972 +2	+0.1%	+$138	﹤0.01%	2095
2026 Q2	$263K	Buy	3,970 +2	+0.1%	+$117	﹤0.01%	2040
2026 Q1	$217K	Buy	+3,968	New	+$221K	﹤0.01%	1963

Other funds holding XPH

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

KFS

Kaizen Financial Strategies Campbell, California $254M AUM 28.38% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Farther Finance Advisors's XPH Position: Q3 2026 in Review

Farther Finance Advisors increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 0.05% in Q3 2026, buying an estimated $138 and bringing the position to 3,972 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #2095.

Farther Finance Advisors first reported a position in XPH in Q1 2026 and has held it in 3 quarters since. The position peaked at $263K in Q2 2026. 4 funds tracked by Wall St. Rank hold XPH as of Q3 2026.

Farther Finance Advisors held 3,972 shares of State Street SPDR S&P Pharmaceuticals ETF worth $258K as of Q3 2026.
Farther Finance Advisors bought 2 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2026, an estimated $138.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2095 holding.
Farther Finance Advisors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2026 and has held it in 3 quarters since.
Farther Finance Advisors's State Street SPDR S&P Pharmaceuticals ETF position peaked at $263K in Q2 2026.
4 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.